# BRINSUPRI - **Website:** - **Primary alias:** `brinsupri.com` ## Description BRINSUPRI, developed by Insmed Incorporated, is a breakthrough prescription medication specifically designed for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adults and children aged 12 and older. As the only approved treatment targeting inflammation caused by neutrophils, BRINSUPRI offers a unique approach to managing this chronic condition, which can lead to lung damage and increased flare-ups. Taken as a once-daily pill, it aims to reduce inflammation and mitigate the risks associated with overactive immune responses. In addition to its therapeutic benefits, BRINSUPRI includes comprehensive safety information, highlighting important considerations for patients, including potential interactions with other medications and the need for regular dental checkups due to possible side effects. Common adverse reactions may include upper respiratory infections, headaches, and skin issues, among others. Overall, BRINSUPRI represents a significant advancement in bronchiectasis treatment, offering hope for patients seeking effective management of their condition. ## Industries - ⛑ Health - ⛑ Biotechnology and Pharmaceuticals _(under Health)_ ## Links - [facebook](https://facebook.com/brinsupri) - [instagram](https://instagram.com/brinsupri_) ## Logos & icons - logo _(primary)_ — PNG, SVG — [download](https://cdn.brandfetch.io/idSgXMGNaY/w/820/h/333/theme/light/logo.png?c=1bxid64Mup7aczewSAYMX&t=1782683706765) - icon _(primary)_ — JPEG — [download](https://cdn.brandfetch.io/idSgXMGNaY/w/321/h/320/theme/dark/icon.jpeg?c=1bxid64Mup7aczewSAYMX&t=1782683706936) ## Colors | Name | Hex | Theme | | --- | --- | --- | | Pastel Green | #80e679 | accent | | Blue Zodiac | #112641 | dark | | White | #ffffff | light | ## Fonts - Gilroy-Regular — asset _(custom)_ - gilroy-bold — asset _(custom)_ --- _Source: _ _See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._